{"database": "openregs", "table": "federal_register", "rows": [["2018-26900", "Biomarker Qualification: Evidentiary Framework; Draft Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry and FDA staff entitled \"Biomarker Qualification: Evidentiary Framework.\" This draft guidance provides recommendations on general considerations to address when developing a biomarker for qualification under the 21st Century Cures Act (Cures Act), enacted on December 13, 2016, that added a new section to the Federal Food, Drug, and Cosmetic Act (FD&C Act). Qualification of a biomarker is a determination that within the stated context of use, the biomarker can be relied on to have a specific interpretation and application in drug development and regulatory review.", "2018-12-12", 2018, 12, "https://www.federalregister.gov/documents/2018/12/12/2018-26900/biomarker-qualification-evidentiary-framework-draft-guidance-for-industry-and-food-and-drug", "https://www.govinfo.gov/content/pkg/FR-2018-12-12/pdf/2018-26900.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry and FDA staff entitled \"Biomarker Qualification: Evidentiary Framework.\" This draft guidance provides recommendations on general...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2018-26900"], "units": {}, "query_ms": 0.5356478504836559, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}